01 1GULBRANDSEN TECHNOLOGIES INC
01 1SUCRALFATE USP
01 1U.S.A
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2025-04-02
Pay. Date : 2025-01-22
DMF Number : 41032
Submission : 2024-12-25
Status : Active
Type : II
20
Gulbrandsen Technologies (india) Private Ltd, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is SUCRALFATE USP, with a corresponding US DMF Number 41032.
Remarkably, this DMF maintains an Active status since its submission on December 25, 2024, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of April 02, 2025, and payment made on January 22, 2025, indicating their dedication to facilitating drug approvals, Categorized as Type II
